학술논문
Benefit Versus Risk Assessment of Melflufen and Dexamethasone in Relapsed/Refractory Multiple Myeloma: Analyses From Longer Follow-up of the OCEAN and HORIZON Studies
Document Type
Article
Author
Source
In Clinical Lymphoma, Myeloma and Leukemia May 2023
Subject
Language
ISSN
2152-2650